CCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer

Purpose: Novel therapeutic targets of estrogen receptor (ER)–positive breast cancers are urgently needed because current antiestrogen therapy causes severe adverse effects, nearly 50% of patients are intrinsically resistant, and the majority of recurrences have maintained ER expression. We investigated the role of estrogen-dependent chemokine expression and subsequent cancer growth in human tissues and experimental breast cancer models. Experimental Design: For in vivo sampling of human chemokines, microdialysis was used in breast cancers of women or normal human breast tissue before and after tamoxifen therapy. Estrogen exposure and targeted therapies were assessed in immune competent PyMT murine breast cancer, orthotopic human breast cancers in nude mice, cell culture of cancer cells, and freshly isolated human macrophages. Cancer cell dissemination was investigated using zebrafish. Results: ER+ cancers in women produced high levels of extracellular CCL2 and CCL5 in vivo, which was associated with infiltration of tumor-associated macrophages. In experimental breast cancer, estradiol enhanced macrophage influx and angiogenesis through increased release of CCL2, CCL5, and vascular endothelial growth factor. These effects were inhibited by anti-CCL2 or anti-CCL5 therapy, which resulted in potent inhibition of cancer growth. In addition, estradiol induced a protumorigenic activation of the macrophages. In a zebrafish model, macrophages increased cancer cell dissemination via CCL2 and CCL5 in the presence of estradiol, which was inhibited with anti-CCL2 and anti-CCL5 treatment. Conclusions: Our findings shed new light on the mechanisms underlying the progression of ER+ breast cancer and indicate the potential of novel therapies targeting CCL2 and CCL5 pathways. Clin Cancer Res; 21(16); 3794–805. ©2015 AACR.

• Publication year

  2015

• Venue

  Clinical Cancer Research

• Publication date

  2015-04-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-15-0204PMID 25901081
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Coexpression and coregulation analysis of time-series gene expression data in estrogen-induced breast cancer cell

  2013cited by this paper
• Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression.

  2012cited by this paper
• Choosing the right cell line for breast cancer research

  2011cited by this paper
• CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis

  2011cited by this paper
• Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

  2011cited by this paper
• Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

  2011cited by this paper
• Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

  2010influential reference
• Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes.

  2010cited by this paper
• Macrophage diversity enhances tumor progression and metastasis.

  2010cited by this paper
• Hypoxia-induced metastasis model in embryonic zebrafish

  2010cited by this paper
• Sex steroids as inflammatory regulators.

  2010cited by this paper
• Macrophages, innate immunity and cancer: balance, tolerance, and diversity.

  2010influential reference
• Stromal MCP‐1 in mammary tumors induces tumor‐associated macrophage infiltration and contributes to tumor progression

  2009cited by this paper
• A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer

  2009cited by this paper
• Estradiol Regulates Expression of Estrogen Receptor ERα46 in Human Macrophages

  2009cited by this paper
• Tamoxifen induces pleiotrophic changes in mammary stroma resulting in extracellular matrix that suppresses transformed phenotypes

  2009cited by this paper
• IL‐1 family in breast cancer: Potential interplay with leptin and other adipocytokines

  2009cited by this paper
• Estradiol Increases IL-8 Secretion of Normal Human Breast Tissue and Breast Cancer In Vivo1

  2009cited by this paper
• The inflammatory chemokines CCL2 and CCL5 in breast cancer.

  2008cited by this paper
• The Yin‐Yang of tumor‐associated macrophages in neoplastic progression and immune surveillance

  2008cited by this paper
• Cancer-related inflammation

  2008cited by this paper
• In vivo measurement of tumor estradiol and Vascular Endothelial Growth Factor in breast cancer patients

  2008cited by this paper
• The tumor microenvironment and its role in promoting tumor growth

  2008cited by this paper
• The Chemokine CCL5 as a Potential Prognostic Factor Predicting Disease Progression in Stage II Breast Cancer Patients

  2006cited by this paper
• Dual role of macrophages in tumor growth and angiogenesis

  2006influential reference
• Chemokines, chemokine receptors, and cancer metastasis

  2006cited by this paper
• Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions.

  2006cited by this paper
• Estradiol increases VEGF in human breast studied by whole-tissue culture

  2006cited by this paper
• Positive Correlation between Estradiol and Vascular Endothelial Growth Factor but not Fibroblast Growth Factor-2 in Normal Human Breast Tissue In vivo

  2005influential reference
• Microdialysis - an in vivo technique for studies of growth factors in breast cancer.

  2005cited by this paper
• Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

  2005cited by this paper
• Estrogen and progesterone receptor expression in macrophages and regulation of hepatocyte growth factor by ovarian steroids in women with endometriosis.

  2005cited by this paper
• Increased extracellular local levels of estradiol in normal breast in vivo during the luteal phase of the menstrual cycle.

  2005cited by this paper
• Variability of vascular endothelial growth factor in normal human breast tissue in vivo during the menstrual cycle.

  2003cited by this paper
• Estradiol increases extracellular levels of vascular endothelial growth factor in vivo in murine mammary cancer

  2003cited by this paper
• IL-1 is required for tumor invasiveness and angiogenesis

  2003cited by this paper
• Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo.

  2003cited by this paper
• Estradiol Promotes Growth and Angiogenesis in Polyoma Middle T Transgenic Mouse Mammary Tumor Explants

  2003cited by this paper
• Increase of Free Insulin-Like Growth Factor-1 in Normal Human Breast in vivo Late in the Menstrual Cycle

  2003cited by this paper
• Animal Model Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases

  2003cited by this paper
• Technical aspects of microdialysis of human breast

  2001cited by this paper
• Estrogen receptor pathways to AP-1.

  2000cited by this paper
• Activation of the human RANTES gene promoter in a macrophage cell line by lipopolysaccharide is dependent on stress-activated protein kinases and the IkappaB kinase cascade: implications for exacerbation of allergic inflammation by environmental pollutants.

  1999cited by this paper
• Variability of glutathione levels in normal breast tissue and subcutaneous fat during the menstrual cycle: an in vivo study with microdialysis technique.

  1997cited by this paper
• Microdialysis of human breast tissue during the menstrual cycle.

  1997cited by this paper
• Cytokine induction of monocyte chemoattractant protein‐1 gene expression in human endothelial cells depends on the cooperative action of NF‐χB and AP‐1

  1997cited by this paper
• Sex steroid hormones and macrophage function.

  1996cited by this paper
• Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.

  1996cited by this paper
• Breast cancer: cause and prevention

  1995cited by this paper
• Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease

  1992cited by this paper
• Estradiol-stimulated growth of MCF-7 tumors implanted in athymic mice: a model to study the tumoristatic action of tamoxifen.

  1988cited by this paper

• Advances in intratumoral immunotherapy from a neuro-immune-endocrine perspective for breast cancer treatment.

  2026cites this paper
• Increased Toll-Like Receptor-4 Signalling in Breast Tissue of High Fibroglandular Density

  2026cites this paper
• The untapped potential of radiation and immunotherapy for hormone receptor-positive breast cancer

  2025cites this paper
• Neoadjuvant Immunotherapy in Hormone Receptor-Positive Breast Cancer: From Tumor Microenvironment Reprogramming to Combination Therapy Strategies

  2025cites this paper
• Sex bias in tumor immunity: insights from immune cells

  2025cites this paper
• Estrogenic control of matrix metalloproteinases: a perspective on breast tumor invasion and metastasis

  2025cites this paper
• Dual roles of innate immune cells and cytokines in shaping the breast cancer microenvironment

  2025cites this paper
• Mechanisms of tumor-associated macrophages in breast cancer and treatment strategy

  2025cites this paper
• Sex-specific cytokine signatures as predictors of anti-PD1 therapy response in non-small cell lung cancer

  2025cites this paper
• CircRHBDD1(4,5)/CCL2 mRNA interaction promotes breast cancer bone metastasis via bone metastatic niche formation.

  2025cites this paper
• Roles of Tumor-Infiltrating Lymphocytes and Antitumor Immune Responses as Predictive and Prognostic Markers in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy

  2025cites this paper
• Significance of the monocyte CCR2-CCL2 axis in triple-negative breast cancer.

  2025cites this paper
• CLEC3A Promotes Immune Evasion and Tumor Progression by Enhancing PD-L1 Stability to Weaken T Cell Cytotoxicity in Luminal Breast Cancer

  2025influential citation
• ERα-dependent crosstalk between macrophages and cancer cells potentiates vasculogenic mimicry and M2 macrophage polarization in bladder cancer

  2025cites this paper
• Sex hormones, the anticancer immune response, and therapeutic opportunities.

  2025cites this paper
• Role of Tumor-Associated Macrophages in Breast Cancer Immunotherapy.

  2025cites this paper
• C-C motif glycoprotein ligand 5 (CCL5) and its GPCR CCR5: Macromolecular game-changers in cancer biology.

  2025cites this paper
• Breast cancer spheroids prefer activated macrophages as an accomplice: An in vitro study

  2024cites this paper
• Roles of Chemokine Axes in Breast Cancer.

  2024cites this paper
• Correlation of Immunomodulatory Cytokines with Tumor Volume and Cerebrospinal Fluid in Vestibular Schwannoma Patients

  2024cites this paper
• Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older women

  2024cites this paper
• Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancer

  2024cites this paper
• Experimental and clinical evidence in favour of an effective immune stimulation in ER-positive, endocrine-dependent metastatic breast cancer

  2024cites this paper
• Estrogen receptor regulation of the Immune Microenvironment in Breast Cancer.

  2024cites this paper
• Zebrafish tumour xenograft models: a prognostic approach to epithelial ovarian cancer

  2024cites this paper
• Regulation of Stromal Cells by Sex Steroid Hormones in the Breast Cancer Microenvironment

  2024cites this paper
• Recent advances targeting chemokines for breast cancer.

  2024cites this paper
• CAR-T cell therapy for breast cancer: Current status and future perspective.

  2024cites this paper
• Influence of tumor microenvironment on the different breast cancer subtypes and applied therapies.

  2024cites this paper
• Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancer

  2024influential citation
• Effect of 12-Week Aerobic Exercise Training on Chemokine Ligands and Their Relative Receptors in Balb/C Mice with Breast Cancer

  2023cites this paper
• Environmental signals perceived by the brain abate pro-metastatic monocytes by dampening glucocorticoids receptor signaling

  2023cites this paper
• The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis

  2023influential citation
• Targeted inhibition of Wnt signaling with a Clostridioides difficile toxin B fragment suppresses breast cancer tumor growth

  2023cites this paper
• Zebrafish: An Emerging Model for Studying Macrophage Functions in Cancer

  2023cites this paper
• Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy

  2023cites this paper
• Sex differences in a murine model of asthma are time and tissue compartment dependent

  2023cites this paper
• A Review of the Effect of Estrogen on Immune Efficacy in Zebrafish (Danio rerio) with Comparisons to Human and Murine Homologs

  2023cites this paper
• MCP‐1 expression in breast cancer and its association with distant relapse

  2023cites this paper
• Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy

  2023cites this paper
• Overview of the therapeutic strategies for ER positive breast cancer.

  2023cites this paper
• The Effects of 4-Week Aerobic Exercise on the Levels of CCl2, CCl5, and their Respective Receptors in Female BALB/C Mice Suffering from Breast Cancer

  2023cites this paper
• Breast density and estradiol are associated with distinct different expression patterns of metabolic proteins in normal human breast tissue in vivo

  2023cites this paper
• Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing

  2023cites this paper
• Antitumor therapy for breast cancer: Focus on tumor‐associated macrophages and nanosized drug delivery systems

  2023cites this paper
• Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer

  2023cites this paper
• The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials.

  2023cites this paper
• A Review of the Effect of Estrogen on Immune Efficacy in Zebrafish (Danio rerio) with Comparisons to Human and Murine Homologs

  2023cites this paper
• Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies

  2022cites this paper
• Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes

  2022cites this paper
• Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast Cancers

  2022cites this paper
• Foods may modify responsiveness to cancer immune checkpoint blockers by altering both the gut microbiota and activation of estrogen receptors in immune cells

  2022cites this paper
• Evolving polarisation of infiltrating and alveolar macrophages in the lung during metastatic progression of melanoma suggests CCR1 as a therapeutic target

  2022cites this paper
• Zebrafish: An Emerging Model for Studying Macrophage Functions in Cancer

  2022cites this paper
• Role of chemokines in the crosstalk between tumor and tumor-associated macrophages

  2022cites this paper
• Immune Checkpoint Blockade in Hormone Receptor-Positive Breast Cancer: Resistance Mechanisms and Future Perspectives.

  2022cites this paper
• Inflammation-Driven Regulation of PD-L1 and PD-L2, and Their Cross-Interactions with Protective Soluble TNFα Receptors in Human Triple-Negative Breast Cancer

  2022cites this paper
• Effects of 8-Week Noncontinuous Aerobic Exercise on the Levels of CCL2, CCL5, and their Respective Receptors in Female BALB/C Mice Suffering from Breast Cancer

  2022cites this paper
• Immunosuppressive tumor microenvironment modulation by chemotherapies and targeted therapies to enhance immunotherapy effectiveness

  2022cites this paper
• Estrogen-induced immune changes within the normal mammary gland

  2022cites this paper
• Estrogen Acts Through Estrogen Receptor-β to Promote Mannan-Induced Psoriasis-Like Skin Inflammation

  2022influential citation
• Zebrafish patient-derived xenograft models predict lymph node involvement and treatment outcome in non-small cell lung cancer

  2022cites this paper
• Like Brothers in Arms: How Hormonal Stimuli and Changes in the Metabolism Signaling Cooperate, Leading HPV Infection to Drive the Onset of Cervical Cancer

  2022cites this paper
• Role of Biological Mediators of Tumor-Associated Macrophages in Breast Cancer Progression.

  2022cites this paper
• Selective estrogen receptor modulators contribute to prostate cancer treatment by regulating the tumor immune microenvironment

  2022cites this paper
• Macrophage-targeted anti-CCL2 immunotherapy enhances tumor sensitivity to 5-fluorouracil in a Balb/c-CT26 murine colon carcinoma model measured using diffuse reflectance spectroscopy

  2022cites this paper
• Bindarit Reduces Bone Loss in Ovariectomized Mice by Inhibiting CCL2 and CCL7 Expression via the NF‐κB Signaling Pathway

  2022cites this paper
• A 13-Gene Signature Based on Estrogen Response Pathway for Predicting Survival and Immune Responses of Patients With UCEC

  2022cites this paper
• Combination treatment with 17β-estradiol and anti-PD-L1 suppresses MC38 tumor growth by reducing PD-L1 expression and enhancing M1 macrophage population in MC38 colon tumor model.

  2022cites this paper
• Persistent Inflammatory Stimulation Drives the Conversion of MSCs to Inflammatory CAFs That Promote Pro-Metastatic Characteristics in Breast Cancer Cells

  2021cites this paper
• CC chemokine ligand 2 (CCL2) stimulates aromatase gene expression in mammary adipose tissue

  2021cites this paper
• Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer

  2021cites this paper
• Sex-Based Differences in the Tumor Microenvironment.

  2021cites this paper
• MCP-1 targeting: Shutting off an engine for tumor development

  2021cites this paper
• Targeting Innate Immunity in Breast Cancer Therapy: A Narrative Review

  2021cites this paper
• Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma.

  2021cites this paper
• Pyroptosis: mechanisms and diseases

  2021cites this paper
• Targeting the ERβ/HER Oncogenic Network in KRAS Mutant Lung Cancer Modulates the Tumor Microenvironment and Is Synergistic with Sequential Immunotherapy

  2021cites this paper
• The Immune Microenvironment in Human Papilloma Virus-Induced Cervical Lesions—Evidence for Estrogen as an Immunomodulator

  2021cites this paper
• Metabolic Hormones Modulate Macrophage Inflammatory Responses

  2021cites this paper
• Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma

  2021cites this paper
• The immunomodulatory effects of endocrine therapy in breast cancer

  2021cites this paper
• Macrophage function in the elderly and impact on injury repair and cancer

  2021cites this paper
• Oestrogen deprivation induces chemokine production and immune cell recruitment in in vitro and in vivo models of oestrogen receptor-positive breast cancer

  2021cites this paper
• Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of ER+ Breast Cancers

  2021influential citation
• miR-1298-5p Influences the Malignancy Phenotypes of Breast Cancer Cells by Inhibiting CXCL11

  2021cites this paper
• CMAR_A_279121 133..145

  2021cites this paper
• Enhancement of E-cadherin expression and processing and driving of cancer cell metastasis by ARID1A deficiency

  2021cites this paper
• Continuous Inflammatory Stimulation Leads via Metabolic Plasticity to a Prometastatic Phenotype in Triple-Negative Breast Cancer Cells

  2021cites this paper
• Tumor-Associated Macrophages as Multifaceted Regulators of Breast Tumor Growth

  2021cites this paper
• Inflammation and tumor progression: signaling pathways and targeted intervention

  2021cites this paper
• Notch Signaling in Embryology and Cancer: Notch Signaling in Cancer

  2021cites this paper
• Notch Signaling and the Breast Cancer Microenvironment.

  2021cites this paper
• SQSTM1/p62 regulate breast cancer progression and metastasis by inducing cell cycle arrest and regulating immune cell infiltration

  2021cites this paper
• Regulation of aromatase in cancer

  2021cites this paper
• Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysis

  2021cites this paper
• Modulating Repolarization of Tumor-Associated Macrophages with Targeted Therapeutic Nanoparticles as a Potential Strategy for Cancer Therapy.

  2021cites this paper
• MicroRNA-200c restoration reveals a cytokine profile to enhance M1 macrophage polarization in breast cancer

  2021cites this paper
• Dare to Compare. Development of Atherosclerotic Lesions in Human, Mouse, and Zebrafish

  2020cites this paper
• Estrogen receptor α promotes lung cancer cell invasion via increase of and cross‐talk with infiltrated macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling pathways

  2020influential citation